Searching map area
TBCRC 022: A Phase II Trial of Neratinib and Capecitabine for Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases
? TBD
scientific article published on 12 March 2019
Join to rate
Ratings 0
Nobody has rated this yet. Be the first!
Lists 0
Join to rate
Instance of
Scholarly article
Author
Michelle E Melisko
Beverly Moy
Eric Winer
Nancy Lin
Rachel A Freedman
Julie Nangia
Ian E Krop
Subject
phase II clinical trial
Capecitabine
References
Wikidata